Company intelligence / Profile preview

Santa Cruz Biotechnology

Dallas, Texas, United Statesscbt.com ↗

Ownership: Private
Employees: ~180
Development stage: Commercial

Overview

Santa Cruz Biotechnology is one of the world’s largest suppliers of antibodies and related biomedical research products. It offers an extensive portfolio including monoclonal antibodies, biochemicals, labware, gene editing tools (CRISPR), siRNAs/shRNAs, proteins/peptides, and other laboratory supplies. The company has faced regulatory scrutiny over animal welfare issues but remains active in supplying life science researchers globally[1][2][3].

Modalities: Monoclonal antibodySmall moleculesiRNA (Small interfering RNA)shRNA (Short hairpin RNA)CRISPR-based productsProteinPeptides
Industry: Non-Drug Biotech

Partnerships

ERS Genomics – licensing agreement for CRISPR/Cas9 technology use in their product portfolio[7]

Beyond the preview

Go deeper on Santa Cruz Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Santa Cruz Biotechnology.

Explore the full profile